Ali Raza Khaki

Cancer Prevention Institute of California

Also affiliated with Palo Alto University, Palo Alto Institute, Stanford Cancer Institute, Stanford University

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.554Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618

Top 58%

0.271DataRank

Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Papers

Driven by 30 papers — median percentile 29. Top paper: “Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study”.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

The Lancet(2020)10.1016/s0140-6736(20)31187-9

N/A

11.9DataRank · unranked

1804 citations

Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera +95 more

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Annals of Oncology(2021)10.1016/j.annonc.2021.02.024

N/A

6.8DataRank · unranked

328 citations

Ali Raza Khaki, Trisha M. Wise‐Draper, Benjamin French, Conor Hennessy, Chih–Yuan Hsu +95 more

Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Cancer(2021)10.1002/cncr.34057

N/A

0.670DataRank · unranked

86 citations

Nicholas Henderson, Marihella James, Divya Natesan, Dory Freeman, Amanda Nizam +31 more

Cancer Therapy Approval Timings, Review Speed, and Publication of Pivotal Registration Trials in the US and Europe, 2010-2019

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.16183

N/A

0.661DataRank · unranked

81 citations

Aakash Desai, Bishal Gyawali, Philip Savage, Jonathan Krell, Jeremy L. Warner +2 more

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes

British Journal of Urology(2021)10.1111/bju.15324

N/A

0.505DataRank · unranked

28 citations

Ali Raza Khaki, Leonidas Nikolaos Diamantopoulos, Lucía Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky +41 more

Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.06.001

N/A

0.505DataRank · unranked

28 citations

Rafee Talukder, Genevieve Ihsiu Lin, Leonidas Nikolaos Diamantopoulos, Scott J. Dawsey, Shilpa Gupta +47 more

Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.08.006

N/A

0.345DataRank · unranked

9 citations

Dimitrios Makrakis, Genevieve Ihsiu Lin, Leonidas Nikolaos Diamantopoulos, Scott J. Dawsey, Shilpa Gupta +49 more

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618

Top 58%

0.271DataRank

Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study

Cancers(2022)10.3390/cancers14174334

N/A

0.269DataRank · unranked

5 citations

Cassandra Hennessy, Alicia Beeghly, Benjamin French, Dimpy P. Shah, Sarah Croessmann +42 more

Who goes first? Patterns of cancer drug approvals across four major regulatory authorities: EMA, FDA, Health Canada, and PMDA.

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.149

N/A

0.232DataRank · unranked

2 citations

Sanjay Mishra, Matthew J. Hadfield, Bishal Gyawali, Andrew J. Cowan, Ali Raza Khaki +3 more

Timing of US Food and Drug Administration (FDA) cancer drug approvals relative to publication of clinical trial results.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2071

N/A

0.165DataRank · unranked

2 citations

Aakash Desai, Martin W. Schoen, Bishal Gyawali, Eddy J. Chen, Peter Yang +2 more

Gender differences in faculty rank and subspecialty choice in academic medical oncology.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11013

Top 70%

0.143DataRank

Top 70%1 citations

Ali Raza Khaki, Alexandra Sokolova, Nancy E. Davidson, Laura Graham

Demographics, outcomes, and risk factors for patients (Pts) with sarcoma and COVID-19: A multi-institutional cohort analysis.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11523

Top 71%

0.140DataRank

Top 71%1 citations

Matthew Ingham, Corrie Painter, Rashmi Chugh, Jonathan C. Trent, Vivek Subbiah +15 more

Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium

The Lancet Healthy Longevity(2022)10.1016/s2666-7568(22)00009-5

N/A

0DataRank · unranked

22 citations

Cassandra Hennessy, Nicole M. Kuderer, Samuel M. Rubinstein, Elizabeth Wulff‐Burchfield, Rachel Rosovsky +45 more

Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad155

N/A

0DataRank · unranked

56 citations

Amin H. Nassar, Gregory R. Pond, Tony Zhuang, Viraj A. Master, Bassel Nazha +50 more

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

The Medicine Forum(2023)10.1101/2023.03.09.23287038

Top 100%

0DataRank

Top 100%0 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Molecularly Targeted Cancer Medications and Kidney Health

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.41221

N/A

0DataRank · unranked

2 citations

Jin Long, Yutong Zhong, Hannah Morgan‐Cooper, Heather A. Wakelee, Ali Raza Khaki +5 more

Neoadjuvant pembrolizumab (pembro) and accelerated methotrexate, vinblastine, doxorubicin, cisplatin (aMVAC) in non-urothelial (non-UC) histologic subtype muscle invasive bladder cancer (MIBC): A phase 2 trial.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.769

N/A

0DataRank · unranked

2 citations

Ali Raza Khaki, Mary W. Redman, Kelsey K. Baker, Aaron Lin, Brianna Woo +15 more

Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0941

N/A

0DataRank · unranked

138 citations

Solange Peters, Orestis A. Panagiotou, Dimpy P. Shah, Nicole M. Kuderer, Chih–Yuan Hsu +40 more

Comparison of Health Care Utilization at the End of Life Among Patients With Cancer in Alberta, Canada, Versus Washington State

JCO Oncology Practice(2020)10.1200/op.20.00217

N/A

0DataRank · unranked

10 citations

Yuan Xu, Winson Y. Cheung, Li Li, Catherine R. Fedorenko, Petros Grivas +3 more

Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2020.10.002

N/A

0DataRank · unranked

19 citations

Sarah K. Holt, Ali Raza Khaki, Rishi Sekar, Adam J. Gadzinski, Yaw A. Nyame +17 more

Trends in FDA cancer registration trial design over time, 1969-2020.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2060

N/A

0DataRank · unranked

7 citations

Tarsheen Sethi, Donna R. Rivera, Neeta K. Venepalli, Travis Osterman, Ali Raza Khaki +2 more

Mismatch between mortality burden and number of FDA registration trials in highly lethal cancers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2072

N/A

0DataRank · unranked

2 citations

Peter Yang, Sam Rubinstein, Martin W. Schoen, Ali Raza Khaki, Jeremy L. Warner +1 more

Assessing the potential cost-effectiveness of the addition of atezolizumab to first-line platinum chemotherapy in advanced urothelial cancer: Implications for value-based pricing.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5031

N/A

0DataRank · unranked

1 citations

Leonidas Nikolaos Diamantopoulos, Marita Zimmerman, Louis P. Garrison, Petros Grivas, Ali Raza Khaki

Histologic subtype and response to immune checkpoint inhibitor (ICI) therapy in advanced urothelial cancer (aUC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.495

N/A

0DataRank · unranked

0 citations

Ali Raza Khaki, Leonidas Nikolaos Diamantopoulos, Mehmet Asım Bilen, Víctor Sacristán Santos, Rafael Morales‐Barrera +15 more

Real-world prognostic model for overall survival (OS) in patients (pts) with advanced urothelial cancer (aUC) treated with immune checkpoint inhibitors (ICI).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.447

Top 100%

0DataRank

Top 100%0 citations

Leonidas Nikolaos Diamantopoulos, Natalie Miller, Mehmet Asım Bilen, Víctor Sacristán Santos, Rafael Morales‐Barrera +15 more

Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center

Open Forum Infectious Diseases(2021)10.1093/ofid/ofab193

N/A

0DataRank · unranked

5 citations

Juhye Lee, Elizabeth M. Krantz, Jessica Morris, Sara Marquis, Pooja Bhattacharyya +11 more

Association of prior local therapy and outcomes with programmed‐death ligand‐1 inhibitors in advanced urothelial cancer

British Journal of Urology(2021)10.1111/bju.15603

N/A

0DataRank · unranked

5 citations

Rafee Talukder, Leonidas Nikolaos Diamantopoulos, Lucía Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky +42 more

Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition (ICI) versus cisplatin-based chemotherapy (CBC) in muscle-invasive bladder cancer (MIBC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.419

N/A

0DataRank · unranked

0 citations

Yong Shan, Richard E. Nelson, Sapna Kaul, John L. Gore, Petros Grivas +2 more

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.4304

N/A

0DataRank · unranked

72 citations

Sonya Reid, Benjamin French, Cassandra Hennessy, Clara Hwang, Na Tosha Gatson +95 more

Ali Raza Khaki

Indexed papers

Top data-sharing exemplar

Papers